Tilray | TRLY - Trade Creditors


Tilray reported $114.5M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 9.42M 1.04M Jun/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Avita Medical AUD 8.96M 1.69M Dec/2025
Canopy Growth CAD 34.82M 14.85M Mar/2026
Cronos Group USD 17.42M 7.14M Jun/2026
Dianthus Therapeutics USD 6.39M 1.12M Jun/2026
Divis Laboratories Ltd INR 12.11B 1.71B Mar/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
IQVIA Holdings USD 3.61B 31M Jun/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Moderna USD 167M 6M Jun/2026
Organigram Holdings CAD 73.14M 2.06M Mar/2026
Organon & Co USD 1.05B 68M Jun/2026
Revvity USD 165.74M 3.94M Jun/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.24B 40.6M Jun/2026
Xeris Pharmaceuticals USD 9.34M 2.13M Jun/2026
Zealand Pharma A/S 171M 175.6M Mar/2026